Population pharmacokinetics of valproate in Chinese children with epilepsy

被引:0
|
作者
De-chun JIANG~(2
~4 Department of Pediatrics
~3 Department of Pharmacology
~5 School of Pharmaceutical Science
机构
基金
中国国家自然科学基金;
关键词
population pharmacokinetics; valproic acid; epilepsy; children; Bayesian method; NONMEM software; individualized dosage regimens;
D O I
暂无
中图分类号
R96 [药理学]; R742.1 [癫痫];
学科分类号
1002 ; 100602 ; 100706 ;
摘要
Aim:The aim of the present study is to establish a population pharmacokinetic(PPK) model of valproate (VPA) in Chinese epileptic children to promote thereasonable use of anti-epileptic drugs.Methods:Sparse data of VPA serumconcentrations from 417 epileptic children were collected.These patients weredivided into 2 groups:the PPK model group (n=317) and the PPK valid group(n=100).The PPK parameter values of VPA were calculated by NONMEM soft-ware using the data of the PPK model group.A basic model and a final modelwere set up.To validate the 2 models,the concentrations of PPK valid groupwere predicted by each model,respectively.The mean prediction error (MPE),mean squared prediction error (MSPE),root mean squared prediction error(RMSPE),weight residues (WRES),and the 95% confidence intervals (95%CI) were also calculated.Then,the values between the 2 models were compared.Results:The PPK of VPA was determined by a 1-compartment model with afirst-order absorption process.The basic model was:Ka=3.09 (h-1),V/F=20.4(L),CL/F=0.296 (L/h).The final model was:Ka=0.251+2.24·(1-HS)(h-1),V/F=2.88+0.157·WT (L),CL/F=0.1060.98·CO+0.0157·AGE (L/h).For thebasic model,the MPE,MSPE,RMSPE,WRES,and the 95% CI were-23.53(-30.36,-16.70),3728.96 (2872.72,4585.20),39.62 (34.34,44.90),and-0.06 (-0.14,0.02),respectively.For the final model,the MPE,MSPE,RMSPE,WRES,and the95% CI were-1.16 (-4.85,2.53),1002.83 (1050.64,1143.61),23.04 (21.12,24.96),and0.08 (-0.04,0.20),respectively.The final model was more optimal than the basicmodel.Conclusion:The PPK model of VPA in Chinese epileptic children wassuccessfully established.It will be valuable to facilitate individualized dosageregimens.
引用
收藏
页码:1677 / 1684
页数:8
相关论文
共 50 条
  • [1] Population pharmacokinetics of valproate in Chinese children with epilepsy
    De-chun Jiang
    Li Wang
    Yu-qin Wang
    Lin Li
    Wei Lu
    Xiang-rong Bai
    [J]. ACTA PHARMACOLOGICA SINICA, 2007, 28 (10) : 1677 - 1684
  • [2] Population pharmacokinetics of valproate in Chinese children with epilepsy
    De-chun Jiang
    Li Wang
    Yu-qin Wang
    Lin Li
    Wei Lu
    Xiang-rong Bai
    [J]. Acta Pharmacologica Sinica, 2007, 28 : 1677 - 1684
  • [3] Population Pharmacokinetics of Valproate in Mexican Children with Epilepsy
    Correa, Tania
    Rodriguez, Ildefonso
    Romano, Silvia
    [J]. BIOPHARMACEUTICS & DRUG DISPOSITION, 2008, 29 (09) : 511 - 520
  • [4] Population pharmacokinetics of lamotrigine in Chinese children with epilepsy
    He, Da-ke
    Wang, Li
    Lu, Wei
    Qin, Jiong
    Zhang, Shen
    Li, Ling
    Zhang, Jian-ming
    Bao, Wei-qun
    Song, Xiao-qing
    Liu, Hai-tao
    [J]. ACTA PHARMACOLOGICA SINICA, 2012, 33 (11) : 1417 - 1423
  • [5] Population pharmacokinetics of topiramate in Chinese children with epilepsy
    Wei, Shifeng
    Li, Xingmeng
    Zhang, Qiang
    Wu, Han
    Wu, Yun
    Zhao, Zhigang
    Mei, Shenghui
    Feng, Weixing
    [J]. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2023, 79 (10) : 1401 - 1415
  • [6] Population pharmacokinetics of lamotrigine in Chinese children with epilepsy
    Da-ke He
    Li Wang
    Jiong Qin
    Shen Zhang
    Wei Lu
    Ling Li
    Jian-ming Zhang
    Wei-qun Bao
    Xiao-qing Song
    Hai-tao Liu
    [J]. Acta Pharmacologica Sinica, 2012, 33 : 1417 - 1423
  • [7] Population pharmacokinetics of topiramate in Chinese children with epilepsy
    Shifeng Wei
    Xingmeng Li
    Qiang Zhang
    Han Wu
    Yun Wu
    Zhigang Zhao
    Shenghui Mei
    Weixing Feng
    [J]. European Journal of Clinical Pharmacology, 2023, 79 : 1401 - 1415
  • [8] Population Pharmacokinetics of Micropakine® a sustained release formulation of valproate in children with epilepsy
    Chhuna, S.
    Chipaux, M.
    Chiron, C.
    Rey, E.
    Pons, G.
    Jullien, V.
    [J]. FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2010, 24 : 59 - 60
  • [9] Valproate population pharmacokinetics in children
    Serrano, BB
    Sánchez, MJG
    Otero, MJ
    Buelga, DS
    Serrano, J
    Domínguez-Gil, A
    [J]. JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS, 1999, 24 (01) : 73 - 80
  • [10] Population pharmacokinetics modeling of levetiracetam in Chinese children with epilepsy
    Wang, Ying-hui
    Wang, Li
    Lu, Wei
    Shang, De-wei
    Wei, Min-ji
    Wu, Ye
    [J]. ACTA PHARMACOLOGICA SINICA, 2012, 33 (06) : 845 - 851